Delivery Order SPE2DR25D3013-SPE2DR26F6X9F
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,842.84 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count) on January 26, 2026, with an ultimate completion date of January 27, 2026. This is a firm fixed-price, non-set-aside contract performed out of the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor and critical vendor in the...
- The Defense Logistics Agency awarded a delivery order valued at $10,676.74 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count packages) on January 16, 2026, with completion targeted for January 20, 2026. This firm fixed-price, competitively awarded contract (no set-aside) is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $29.4K to supply NURTEC ODT 75 MG tablets (8-count units) with a firm fixed price structure. This non-competitive delivery order is set to be completed by January 23, 2026, and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor serving federal healthcare systems, and the company is...
- The Defense Logistics Agency awarded a $3,840.49 delivery order to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count packaging) with a completion date of January 27, 2026. This contract represents a firm fixed-price purchase under a non-set-aside, competitively awarded vehicle. The awardee, AmerisourceBergen Drug Corp, is headquartered in Conshohocken, Pennsylvania, and operates as a subsidiary of parent company Cencora, Inc. (formerly known as AmerisourceBergen)....
- The Defense Logistics Agency awarded a $14.87K firm fixed-price delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count units) on January 14, 2026, with completion scheduled for January 15, 2026. This non-set-aside award represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999.99M through December 2031. The IDC serves as a comprehensive global...
- The Defense Logistics Agency awarded a delivery order valued at $10,522.29 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 MG tablets (quantity 8 units) on January 15, 2026, with an ultimate completion date of January 16, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation. The contract will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent...
- The Defense Logistics Agency awarded a delivery order valued at $12,522.79 to Amerisourcebergen Drug Corp for NURTEC ODT 75 MG tablets (8 count) on January 23, 2026, with an ultimate completion date of January 26, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The award was performed at Amerisourcebergen's corporate office location in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a major...
- The Defense Logistics Agency awarded a delivery order valued at $51,160.29 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 MG tablets (8-count units) on January 15, 2026, with completion scheduled for January 16, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc.,...
- The Defense Logistics Agency awarded a $6,098.66 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count unit) on January 6, 2026, with an ultimate completion date of January 7, 2026. This is a firm fixed-price, non-set-aside contract performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a task against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive...
- The Defense Logistics Agency awarded a delivery order valued at $8,908.31 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packaging) on January 13, 2026, with completion scheduled for January 14, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a task order issued under AmerisourceBergen's larger...
- SPE2DR25D3013Indefinite Delivery Contract
- SPE2DR25D3013-SPE2DR26F6X9FDelivery Order
The Defense Logistics Agency awarded a delivery order valued at approximately $14K to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 MG tablets (8-count units) on January 26, 2026, with completion scheduled for January 27, 2026. This is a firm fixed-price, non-set-aside contract performed at the awardee's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at up to $999,999,999 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the supply of a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies. The contract was competitively awarded, demonstrating the contractor's capability to meet federal pharmaceutical procurement requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.0k | 1/25/26 |